These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of chronic immune thrombocytopenia in children with romiplostim. Chaturvedi S; McCrae KR Lancet; 2016 Jul; 388(10039):4-6. PubMed ID: 27103125 [No Abstract] [Full Text] [Related]
4. Remissions after long-term use of romiplostim for immune thrombocytopenia. Marshall AL; Scarpone R; De Greef M; Bird R; Kuter DJ Haematologica; 2016 Dec; 101(12):e476-e478. PubMed ID: 27587382 [No Abstract] [Full Text] [Related]
5. Safety and efficacy of romiplostim in patients with eltrombopag-resistant or -intolerant immune thrombocytopenia. Tsukamoto S; Nakaseko C; Takeuchi M; Kumagai K; Komatsu T; Tanaka H; Hara S; Koizumi M; Imai H; Yokota A; Takeuchi M; Inokuchi K; Matsuura Y; Aotsuka N; Wakita H Br J Haematol; 2013 Oct; 163(2):286-9. PubMed ID: 23862773 [No Abstract] [Full Text] [Related]
6. Effectiveness of thrombopoietin-receptor agonists in the treatment of refractory immune thrombocytopenia associated to systemic lupus erythematosus. Magnano L; Enríquez H; Esteve J; Cervera R; Espinosa G J Rheumatol; 2014 Sep; 41(9):1895-6. PubMed ID: 25179983 [No Abstract] [Full Text] [Related]
7. The association of rituximab and a thrombopoietin receptor agonist in high-risk refractory immune thrombocytopenic purpura. Veneri D; Soligo L; Pizzolo G; Ambrosetti A Blood Transfus; 2015 Oct; 13(4):694-5. PubMed ID: 26057496 [No Abstract] [Full Text] [Related]
8. Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura. Gardiner EE; Thom JY; Al-Tamimi M; Hughes A; Berndt MC; Andrews RK; Baker RI Br J Haematol; 2010 May; 149(4):625-8. PubMed ID: 20148887 [No Abstract] [Full Text] [Related]
9. Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. Decroocq J; Marcellin L; Le Ray C; Willems L Obstet Gynecol; 2014 Aug; 124(2 Pt 2 Suppl 1):481-483. PubMed ID: 25004319 [TBL] [Abstract][Full Text] [Related]
10. Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2-month-old infant. Chiba Y; Tasaka K; Matsubara K; Mori M; Muraoka M; Hamabata T; Nodomi S; Waki K Pediatr Blood Cancer; 2024 Jun; 71(6):e30953. PubMed ID: 38520052 [No Abstract] [Full Text] [Related]
11. Use of a thrombopoietin mimetic for chronic immune thrombocytopenic purpura in pregnancy. Patil AS; Dotters-Katz SK; Metjian AD; James AH; Swamy GK Obstet Gynecol; 2013 Aug; 122(2 Pt 2):483-485. PubMed ID: 23884268 [TBL] [Abstract][Full Text] [Related]
12. Plateletpheresis for postsplenectomy rebound thrombocytosis in a patient with chronic immune thrombocytopenic purpura on romiplostim. Raval JS; Redner RL; Kiss JE J Clin Apher; 2013 Aug; 28(4):321-4. PubMed ID: 23450778 [TBL] [Abstract][Full Text] [Related]
13. Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report. Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C Blood Coagul Fibrinolysis; 2012 Jun; 23(4):331-4. PubMed ID: 22343685 [TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin receptor agonists as an emergency treatment for severe newly diagnosed immune thrombocytopenia in children. Nolla M; Aladjidi N; Leblanc T; Fernandes H; Ducassou S; Fahd M; Barlogis V; Michel M; Blouin P; Jeziorski E; Benadiba J; Pondarre C; Leverger G; Pasquet M Blood; 2021 Jan; 137(1):138-141. PubMed ID: 33410895 [No Abstract] [Full Text] [Related]
15. Sequential treatment with thrombopoietin-receptor agonists (TPO-RAs) in immune thrombocytopenia (ITP): experience in our center. González KJ; Zuluaga SO; DaRos CV; Rodríguez PP; Martí AC Ann Hematol; 2017 Mar; 96(3):507-508. PubMed ID: 27975127 [No Abstract] [Full Text] [Related]
16. The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim. Al-Samkari H; Schifferli A; Gonzalez-Lopez TJ Br J Haematol; 2024 Apr; 204(4):1143-1145. PubMed ID: 38319005 [TBL] [Abstract][Full Text] [Related]
17. Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia. Al-Samkari H; Kuter DJ Br J Haematol; 2018 Oct; 183(2):168. PubMed ID: 29978577 [No Abstract] [Full Text] [Related]
18. Romiplostim for management of refractory immune thrombocytopenic purpura in the immediate postpartum period. Patras A; Figueroa R; Singh AP; Madan I BMJ Case Rep; 2020 May; 13(5):. PubMed ID: 32430352 [TBL] [Abstract][Full Text] [Related]
19. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study. Tarantino MD; Bussel JB; Blanchette VS; Despotovic J; Bennett C; Raj A; Williams B; Beam D; Morales J; Rose MJ; Carpenter N; Nie K; Eisen M Lancet; 2016 Jul; 388(10039):45-54. PubMed ID: 27103127 [TBL] [Abstract][Full Text] [Related]